Skip to main content
Latest Update
2026-11-20 14:13 UTC

OpenAI debuts GPT-Rosalind to advance neurodegenerative R&D

OpenAI debuts GPT-Rosalind to advance neurodegenerative R&D

According to OpenAI via X, GPT-Rosalind is being used with PerturbAI and Scripps Research to surface new leads for understanding and treating neurodegenerative diseases.

Source

Analysis

OpenAI is applying AI through GPT-Rosalind in a collaboration with PerturbAI and Scripps Research to generate new leads for understanding and treating neurodegenerative diseases, according to a post by Greg Brockman referencing an OpenAI announcement.

This approach uses AI to process complex biological datasets, which boosts scientist productivity by accelerating hypothesis generation in research workflows and highlights expanding roles for AI models within the life sciences ecosystem.

Greg Brockman

@gdb

President & Co-Founder of OpenAI